Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Mar 1.

Published in final edited form as: Leukemia. 2021 Mar 2;35(9):2539–2551. doi: 10.1038/s41375-021-01179-4

Figure 2. — Cumulative incidence of relapse (CIR) for 441 CRind patients with either non-AML death or non-AML death and transplantation as competing risks, (a,b) overall and (c-h) for the 282 CRind patients with available cytogenetic and molecular data by ELN 2017 risk classification.

Figure 2. — Cumulative incidence of relapse (CIR) for 441 CRind patients with either non-AML death or non-AML death and transplantation as competing risks, (a,b) overall and (c-h) for the 282 CRind patients with available cytogenetic and molecular data by ELN 2017 risk classification.